映恩生物-B：拟发行将于科创板上市并以人民币买卖的普通股

Core Viewpoint - The company, Ying'en Biotechnology-B, announced plans to issue ordinary shares for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board, subject to market conditions and necessary approvals [1] Group 1 - The board of directors has resolved to issue shares that will be traded in RMB [1] - The issuance is contingent upon further approval from the board, shareholder meeting, and regulatory authorities [1]